JohnPatrickChuteMD

Hematologic Oncology

Professor, Medicine, Duke Univ Sch of Med

Dr. Chute is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1993 - 1996
Georgetown University School of MedicineClass of 1990

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Elected Member The American Society for Clinical Investigation, 2010

PubMed

Alteration of Neuropilin-1 and Heparan Sulfate Interaction Impairs Murine B16 Tumor Growth.
Chelsea D Painter, Nehru Viji Sankaranarayanan, Balaji Nagarajan, Thomas Mandel Clausen, Alan M V West
ACS Chemical Biology. 2024-08-16
Epidermal growth factor augments the self-renewal capacity of aged hematopoietic stem cells.
Vivian Y Chang, Yuwei He, Samantha Grohe, Morgan R Brady, Aldi Chan
Iscience. 2024-07-19
Inhibition of Ephrin B2 Reverse Signaling Abolishes Multiple Myeloma Pathogenesis.
Joshua P Sasine, Natalia Y Kozlova, Lisa Valicente, Jennifer Dukov, Dana H Tran
Cancer Research. 2024-03-15

A Leading-Edge Lymphoma ProgramDecember 21st, 2022
Stem Cell Discovery Could Help Shorten Cancer Treatment RecoveryFebruary 2nd, 2022
Discoveries Could Lead to Better Stem Cell TreatmentsJanuary 31st, 2022
Join now to see all